Autonomix Medical, Inc. 8-K

What Happened

• Autonomix Medical, Inc. (AMIX) announced a board-approved 1-for-21 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on June 24, 2026. Stockholders approved a potential reverse split (1-for-2 to 1-for-25) at the company’s Oct. 30, 2025 annual meeting; the board selected 1:21 and filed the Certificate of Amendment with the Delaware Secretary of State. The company will continue trading on Nasdaq under the ticker "AMIX" with a new CUSIP number 05330T304.
• At the Effective Time every 21 issued and outstanding shares will be combined into one share (par value remains $0.001). Outstanding shares are expected to drop from 11,409,344 to approximately 542,000. Fractional shares will not be issued; holders entitled to fractions will receive cash (without interest) equal to the fraction times the average closing price over the five trading days before the split.

Key Details

• Effective date/time: 12:01 a.m. ET on June 24, 2026; Nasdaq ticker remains AMIX; new CUSIP 05330T304.
• Outstanding shares reduced from 11,409,344 to ~542,000; authorized common shares remain 500 million.
• Stock options, warrants and equity plan reservations will be adjusted proportionately (fewer shares reserved, higher exercise prices).
• Financial presentation: net loss for year ended March 31, 2026 was $16,715 thousand and $11,410 thousand for 2025 (amounts unchanged). Weighted average shares and net loss per share were retroactively adjusted to reflect the split:
  • Pre-split weighted average shares (basic & diluted): 7,216,757 (2026) and 1,766,425 (2025)
  • Post-split weighted average shares: 342,539 (2026) and 83,020 (2025)
  • Net loss per share (basic & diluted) pre-split: $(2.32) (2026), $(6.46) (2025); post-split: $(48.80) (2026), $(137.44) (2025).

Why It Matters

• The reverse split reduces the number of shares outstanding and increases the per-share figures (price and per-share losses) without changing the company’s aggregate equity value in theory. Investors will see larger per-share metrics (e.g., loss per share) because the share count is lower.
• Outstanding stock options and warrants will be adjusted, which affects potential dilution and exercise economics. Fractional-share cash-outs may affect small shareholders.
• The split may influence trading liquidity and per-share pricing comparisons; holders should check post-split share counts on their statements and expect administrative adjustments from the transfer agent and DTCC.